[go: up one dir, main page]

AP2006003575A0 - Muscarinic acetylcholine receptor antagonists. - Google Patents

Muscarinic acetylcholine receptor antagonists.

Info

Publication number
AP2006003575A0
AP2006003575A0 AP2006003575A AP2006003575A AP2006003575A0 AP 2006003575 A0 AP2006003575 A0 AP 2006003575A0 AP 2006003575 A AP2006003575 A AP 2006003575A AP 2006003575 A AP2006003575 A AP 2006003575A AP 2006003575 A0 AP2006003575 A0 AP 2006003575A0
Authority
AP
ARIPO
Prior art keywords
receptor antagonists
acetylcholine receptor
muscarinic acetylcholine
muscarinic
antagonists
Prior art date
Application number
AP2006003575A
Other languages
English (en)
Inventor
Michael R Palovich
Zehong Wan
Chongjie Zhu
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AP2006003575A0 publication Critical patent/AP2006003575A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2006003575A 2003-10-17 2004-10-15 Muscarinic acetylcholine receptor antagonists. AP2006003575A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51216103P 2003-10-17 2003-10-17
PCT/US2004/034234 WO2005037224A2 (en) 2003-10-17 2004-10-15 Muscarinic acetylcholine receptor antagonists

Publications (1)

Publication Number Publication Date
AP2006003575A0 true AP2006003575A0 (en) 2006-04-30

Family

ID=34465319

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003575A AP2006003575A0 (en) 2003-10-17 2004-10-15 Muscarinic acetylcholine receptor antagonists.

Country Status (22)

Country Link
US (1) US7507747B2 (xx)
EP (1) EP1677796A4 (xx)
JP (1) JP2007509061A (xx)
CN (1) CN1897947A (xx)
AP (1) AP2006003575A0 (xx)
AR (1) AR046114A1 (xx)
AU (1) AU2004281167A1 (xx)
BR (1) BRPI0415281A (xx)
CA (1) CA2542636A1 (xx)
EA (1) EA200600787A1 (xx)
EC (1) ECSP066486A (xx)
IL (1) IL174846A0 (xx)
IS (1) IS8440A (xx)
MA (1) MA28109A1 (xx)
MX (1) MXPA06004242A (xx)
NO (1) NO20062071L (xx)
OA (1) OA13270A (xx)
PE (1) PE20050442A1 (xx)
TW (1) TW200528448A (xx)
UY (1) UY28567A1 (xx)
WO (1) WO2005037224A2 (xx)
ZA (1) ZA200602783B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (es) * 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
TW200524577A (en) * 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
WO2005087236A1 (en) * 2004-03-11 2005-09-22 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
JP2007529513A (ja) * 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
US20070185148A1 (en) * 2004-03-17 2007-08-09 Glaxo Group Limited M3 muscarinic acetylchoine receptor antagonists
TWI363759B (en) 2004-04-27 2012-05-11 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2007537261A (ja) * 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
WO2006055553A2 (en) * 2004-11-15 2006-05-26 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
WO2007016639A2 (en) * 2005-08-02 2007-02-08 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
US7767691B2 (en) * 2005-08-18 2010-08-03 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system
TW200946526A (en) 2008-02-06 2009-11-16 Glaxo Group Ltd Dual pharmacophores-PDE4-muscarinic antagonistics
CL2009000250A1 (es) 2008-02-06 2009-09-11 Glaxo Group Ltd Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis.
AR070563A1 (es) 2008-02-06 2010-04-21 Glaxo Group Ltd Compuesto de un biciclo condensado pirazol-piridin-amina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de enfermedades respiratorias.
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800481A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (de) * 1967-06-08 1972-04-25 Siemens Ag Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens
GB2064336B (en) 1979-12-06 1984-03-14 Glaxo Group Ltd Device for dispensing medicaments
ATE23272T1 (de) 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
US4627432A (en) 1982-10-08 1986-12-09 Glaxo Group Limited Devices for administering medicaments to patients
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
NZ217006A (en) 1985-07-30 1989-04-26 Glaxo Group Ltd Inhaler for finely divided medicament includes plunger to open medicament container
IT1204826B (it) 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US5780466A (en) * 1995-01-30 1998-07-14 Sanofi Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
US6350758B1 (en) * 1996-12-02 2002-02-26 Georgetown University Tropane derivatives and method for their synthesis
US6248752B1 (en) * 1998-02-27 2001-06-19 Charles Duane Smith Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1263758A2 (en) * 2000-03-03 2002-12-11 Ortho-McNeil Pharmaceutical, Inc. 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
RU2004110717A (ru) * 2001-10-17 2005-10-20 Юсиби, С.А. (Be) Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов
US6696462B2 (en) * 2002-01-31 2004-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
UY27927A1 (es) * 2002-08-06 2003-12-31 Glaxo Group Ltd Antagonistas del receptor muscarínico m3 de acetilcolina
JP2006522161A (ja) * 2003-04-07 2006-09-28 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体拮抗剤
TW200519109A (en) * 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
PE20050250A1 (es) * 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
PE20050327A1 (es) * 2003-07-17 2005-06-08 Glaxo Group Ltd Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina
EP1677795B1 (en) * 2003-10-14 2011-01-05 Glaxo Group Limited Muscarinic acetycholine receptor antagonists
TW200524577A (en) * 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
ES2329586T3 (es) * 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
AR046783A1 (es) * 2003-12-03 2005-12-21 Glaxo Group Ltd Compuesto de sal ciclica de amonio cuaternario composicion farmaceutica que lo comprende y su uso para preparar esta ultima
UY28645A1 (es) * 2003-12-03 2005-06-30 Glaxo Group Ltd Nuevos antagonistas del receptor muscarinico m3 de acetilcolina
WO2005094835A1 (en) * 2004-03-17 2005-10-13 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
JP2007529513A (ja) * 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
US20070185148A1 (en) * 2004-03-17 2007-08-09 Glaxo Group Limited M3 muscarinic acetylchoine receptor antagonists
US20070185090A1 (en) * 2004-03-17 2007-08-09 Jakob Busch-Petersen Muscarinic acetylchoine receptor antagonists
TWI363759B (en) * 2004-04-27 2012-05-11 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2007537261A (ja) * 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
JP2008501020A (ja) * 2004-05-28 2008-01-17 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
WO2006055553A2 (en) 2004-11-15 2006-05-26 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
WO2006055503A2 (en) 2004-11-15 2006-05-26 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
PE20060826A1 (es) 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
PE20061162A1 (es) 2004-12-06 2006-10-14 Smithkline Beecham Corp Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
WO2006065788A2 (en) 2004-12-13 2006-06-22 Glaxo Group Limited Novel muscarinic acetylcholine receptor antagonists
WO2006065755A2 (en) 2004-12-13 2006-06-22 Glaxo Group Limited Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists
WO2007018514A1 (en) 2005-07-28 2007-02-15 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en) 2005-07-28 2007-02-15 Glaxo Group Limited Novel m3 muscarinic acetycholine receptor antagonists

Also Published As

Publication number Publication date
PE20050442A1 (es) 2005-07-09
CA2542636A1 (en) 2005-04-28
EA200600787A1 (ru) 2006-08-25
UY28567A1 (es) 2005-05-31
IL174846A0 (en) 2006-08-20
IS8440A (is) 2006-05-05
ECSP066486A (es) 2006-10-10
US20070135478A1 (en) 2007-06-14
EP1677796A2 (en) 2006-07-12
AR046114A1 (es) 2005-11-23
WO2005037224A3 (en) 2005-06-23
WO2005037224A2 (en) 2005-04-28
CN1897947A (zh) 2007-01-17
US7507747B2 (en) 2009-03-24
JP2007509061A (ja) 2007-04-12
NO20062071L (no) 2006-05-08
MXPA06004242A (es) 2006-06-28
TW200528448A (en) 2005-09-01
MA28109A1 (fr) 2006-08-01
ZA200602783B (en) 2007-11-28
BRPI0415281A (pt) 2006-12-19
OA13270A (en) 2007-01-31
EP1677796A4 (en) 2006-12-27
AU2004281167A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
AP2213A (en) Muscarinic acetylcholine receptor antagonists.
IL188112A0 (en) Muscarinic acetylcholine receptor antagonists
PL1682142T3 (pl) Antagoniści muskarynowego receptora M₃ acetylocholiny
AU2003261392A8 (en) M3muscarinic acetylcholine receptor antagonists
EP1725240A4 (en) ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR
AP2006003478A0 (en) Muscarinic acetylcholine receptor antagonists.
IL176078A0 (en) Novel m3 muscarinic acetylcholine receptor antagonists
IL175995A0 (en) Novel m3 muscarinic acetylcholine receptor antagonists
IL172912A0 (en) Muscarinic acetylcholine receptor antagonists
IL172911A0 (en) Muscarinic acetylcholine receptor antagonists
IL176775A0 (en) Muscarinic acetylcholine receptor antagonists
AP2006003575A0 (en) Muscarinic acetylcholine receptor antagonists.
EP1749012A4 (en) ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
EP1824483A4 (en) ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS
EP1725241A4 (en) ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC M3 RECEPTOR
EP1725564A4 (en) ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR
EP1765339A4 (en) ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
EP1781104A4 (en) ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR
EP1781103A4 (en) ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR
HK1092355A (en) Muscarinic acetylcholine receptor antagonists
HK1089664A (en) Muscarinic acetylcholine receptor antagonists
HK1089662A (en) Muscarinic acetylcholine receptor antagonists
HK1089663A (en) Muscarinic acetylcholine receptor antagonists
HK1097450A (en) Muscarinic acetylcholine receptor antagonists